This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
projects:workgroups:kb-wg [2015/01/16 18:39] rkboyce [Meetings] |
projects:workgroups:kb-wg [2017/02/11 17:52] rkboyce |
||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== Knowledgebase (LAERTES) Workgroup ====== | + | ====== Pharmacovigilance evidence investigation Workgroup (used to be Knowledge Base / LAERTES) ====== |
<WRAP box justify round> | <WRAP box justify round> | ||
Line 7: | Line 7: | ||
**Project Lead:** [[http://ohdsi.org/who-we-are/collaborators/richard-d-boyce-2/|Richard D. Boyce, PhD]] | **Project Lead:** [[http://ohdsi.org/who-we-are/collaborators/richard-d-boyce-2/|Richard D. Boyce, PhD]] | ||
- | **Project Co-Lead:** [[http://ohdsi.org/who-we-are/collaborators/1045-2/|Patrick Ryan, PhD]] | + | **Project Co-Lead:** [[http://ohdsi.org/who-we-are/collaborators/erica-voss/|Erica Voss, MPH]] |
**Members:** | **Members:** | ||
- | See [[kb-wg#internal|Members List]] | + | See [[kb-wg#internal|Members List]] but note that active membership is completely voluntary and open. |
**Start Date:** 6/10/2014 | **Start Date:** 6/10/2014 | ||
Line 17: | Line 17: | ||
**Repository:** [[https://github.com/OHDSI/KnowledgeBase]] | **Repository:** [[https://github.com/OHDSI/KnowledgeBase]] | ||
- | **WG Minutes:** [[https://docs.google.com/document/d/1T3TlmtkCL0BCNMJAUY76h4EV2mapEMAclaRFgmY_zzE/edit?usp=drive_web|Knowledge Base WG Minutes]] | + | **WG Minutes:** [[https://docs.google.com/document/d/1T3TlmtkCL0BCNMJAUY76h4EV2mapEMAclaRFgmY_zzE/edit?usp=drive_web|WG Minutes]] |
+ | |||
+ | **WG Agendas:** [[http://forums.ohdsi.org/t/laertes-team-meeting-agenda/172| WG Agendas]] | ||
+ | |||
+ | **Publications:** | ||
+ | Boyce. RD., Ryan. PB., Noren. N., et al., Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Safety. 2014. Volume 37, Issue 8 (2014), Page 557-567. DOI: 10.1007/s40264-014-0189-0, PubMed PMID: 24985530. PMCID: PMC4134480. http://link.springer.com/article/10.1007%2Fs40264-014-0189-0 | ||
+ | |||
+ | E.A. Voss, R.D. Boyce, P.B. Ryan, J. van der Lei, P.R. Rijnbeek, M.J. Schuemie, Accuracy of an Automated Knowledge Base for Identifying Drug Adverse Reactions, Journal of Biomedical Informatics, Available online 16 December 2016, ISSN 1532-0464, http://dx.doi.org/10.1016/j.jbi.2016.12.005. | ||
+ | |||
+ | Boyce, RD., Voss, E., Huser, V., Evans, L., Reich, C., Duke, JD., Tatonetti, NP., Lorberbaum, T., Dumontier, M., Hauben, M., Wallberg, M., Peng, L., Dempster, S., He, O., Sena, A., Koutkias, V., Natsiavas, P., Ryan, P. LAERTES: An open system architecture for linking pharmacovigilance evidence sources with clinical data. Journal of Biomedical Semantics. Accepted on 1/3/2017. In Process. | ||
- | **WG Agendas:** [[http://forums.ohdsi.org/t/laertes-team-meeting-agenda/172|Knowledge Base WG Agendas]] | ||
</WRAP> | </WRAP> | ||
Line 25: | Line 34: | ||
==== Meetings (Telecon Info) ==== | ==== Meetings (Telecon Info) ==== | ||
- | Schedule: Every other Wednesday at 12 Eastern starting from January 14th 2015 | + | Schedule: Once per month schedule: |
- | Please join my meeting. | + | |
- | https://global.gotomeeting.com/join/530277469 | + | |
- | You can call in for audio: | ||
- | Dial +1 (646) 749-3122 | ||
- | Access Code: 530-277-469 | ||
- | === Discussions === | + | Feb - Tues 6th at 3pm Eastern |
- | [[http://forums.ohdsi.org/t/laertes-api/128|Laertes API]] | ||
- | [[http://forums.ohdsi.org/t/laertes-update-of-the-pharmacovigilance-signals/173/1|update of the pharmacovigilance signals]] | + | Please join my meeting. |
+ | https://global.gotomeeting.com/join/530277469 | ||
- | [[http://forums.ohdsi.org/t/laertes-pre-load-queries-hoi-from-x-to-snomed-rxnorm-bd-to-cd/180|LAERTES: pre-load queries - hoi from X to snomed, rxnorm BD to CD]] | + | Use your microphone and speakers (VoIP) - a headset is recommended. |
+ | |||
+ | Or, call in using your telephone: | ||
+ | |||
+ | United States: +1 (224) 501-3217 | ||
+ | Sweden: +46 (0) 853 527 836 | ||
+ | |||
+ | Access Code: 530-277-469 | ||
+ | |||
+ | === Discussions === | ||
- | [[http://forums.ohdsi.org/t/laertes-getting-the-pivot-correct-rolling-up-from-clinical-drug-to-ingredient/181|LAERTES: getting the pivot correct - ‘rolling up’ from clinical drug to ingredient]] | + | Search for "LAERTES" on [[http://forums.ohdsi.org/]] |
=== GitHub Issues === | === GitHub Issues === | ||
- | {{ghissues OHDSI/KnowledgeBase state:open}} | + | [[https://github.com/OHDSI/KnowledgeBase/issues]] |
=== Members List === | === Members List === | ||
- | - Abraham G. Hartzema, PhD, University of Florida, Gainesville, FL | + | Richard D. Boyce, University of Pittsburgh, Pittsburgh, PA, rdb20@pitt.edu |
+ | |||
+ | Erica A. Voss, Janssen Research & Development, LLC, Titusville, NJ, EVoss3@its.jnj.com | ||
- | - Christian Reich, MD, PhD, AstraZeneca, Waltham MA | + | Vojtech Huser, National Institutes of Health, Bethesda, MD, vojtech.huser@nih.gov |
- | - Christophe Lambert, PhD, University of New Mexico, Albuquerque, NM | + | Lee Evans, LTS Computing LLC, West Chester, PA, levans@ltscomputingllc.com |
- | - Erica A. Voss, MPH, Janssen Research and Development, Titusville, PA | + | Christian Reich, QuintilesIMS, Burlington MA, reich@ohdsi.org |
- | - Gianluca Trifirò, PhD, University of Messina, Messina, Italy & Erasmus University Medical Center, Rotterdam, Netherlands | + | Jon D. Duke, Georgia Tech Research Institute, Atlanta, GA, Jon.Duke@gatech.edu |
- | - J. Marc Overhage, MD, PhD, Siemens Healthcare, Malvern, PA | + | Nicholas P. Tatonetti, Herbert Irving Assistant Professor of Biomedical Informatics, Columbia University, New York, NY, nick.tatonetti@columbia.edu |
- | - Jon Duke, MD, Regenstrief Institute, Indianapolis IN | + | Tal Lorberbaum, Columbia University, New York, NY, tal.lorberbaum@columbia.edu |
- | - Johan Ellenius, PhD, Uppsala Monitoring Centre, Uppsala, Sweden | + | Michel Dumontier, Stanford University, Stanford, CA, michel.dumontier@gmail.com |
- | - Lee Evans, LTS Computing LLC, Exton, PA | + | Manfred Hauben, MD. MPH, Pfizer Inc, New York University Medical Center, New York, NY, manfred.hauben@pfizer.com |
- | - Majid Rastegar-Mojarad, MS, Mayo Clinic, Rochester, MN | + | Magnus Wallberg, Uppsala Monitoring Centre, Uppsala, Sweden, Magnus.Wallberg@who-umc.org |
- | - Mark Khayter, BS, Ephir, Boston, MA | + | Lili Peng, AstraZeneca R&D, Boston , MA, Lili.Peng@astrazeneca.com |
- | - Martijn J. Schuemie, PhD, Janssen Research and Development, Titusville, PA | + | Sara Dempster, AstraZeneca R&D, Boston , MA, sara.dempster@astrazeneca.com |
- | - Michel Dumontier, PhD, Stanford University, Stanford, CA | + | Yongqun He, University of Michigan Medical School, Ann Arbor, Michigan, yongqunh@med.umich.edu |
- | - Nicholas P. Tatonetti, PhD, Columbia University, New York, NY | + | Anthony G. Sena, Janssen Research & Development, LLC, Titusville, NJ, asena5@its.jnj.com |
- | - Niklas Noren, PhD, Uppsala Monitoring Centre, Uppsala, Sweden | + | Vassilis Koutkias, Institute of Applied Biosciences, Center for Research & Technology Hellas, Thermi, Thessaloniki, Greece, vkoutkias@certh.gr |
- | - Rave Harpaz, PhD, Stanford University, Palo Alto, CA | + | Pantelis Natsiavas, Institute of Applied Biosciences, Center for Research & Technology Hellas, Thermi, Thessaloniki, Greece, pnatsiavas@certh.gr |
- | - Vojtech Huser, MD PhD, National Institutes of Health, Bethesda, MD | + | Patrick B. Ryan, Janssen Research & Development, LLC, Titusville, NJ, ryan@ohdsi.org |